AGP Picks
View all

Macao Technology Network
Provided by AGP

Macao Technology Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Macao Technology Network.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 28, 2026

Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
an hour ago

Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam

Indeterminate GlobeNewswire
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
an hour ago

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Indeterminate GlobeNewswire
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
an hour ago

VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement

Indeterminate GlobeNewswire
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
2 hours ago

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

Indeterminate GlobeNewswire
Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3  
2 hours ago

Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3  

Indeterminate GlobeNewswire
argenx to Host Myositis R&D Webinar on June 23, 2026
2 hours ago

argenx to Host Myositis R&D Webinar on June 23, 2026

Indeterminate GlobeNewswire
SPARC AI Inc. Announces Brokered LIFE Financing of Up to $5.46 Million
4 hours ago

SPARC AI Inc. Announces Brokered LIFE Financing of Up to $5.46 Million

Indeterminate GlobeNewswire
Sportradar Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Sportradar Group AG - SRAD
4 hours ago

Sportradar Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Sportradar Group AG - SRAD

Indeterminate GlobeNewswire
SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES
4 hours ago

SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES

Indeterminate GlobeNewswire
TSplus Expands in Malaysia Through Strategic Smart City Partnership with Kangar Municipal Council and Aswant
6 hours ago

TSplus Expands in Malaysia Through Strategic Smart City Partnership with Kangar Municipal Council and Aswant

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Macao Technology Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.